In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...

Pittcon 2025 in Boston: a landmark event uniting industry and academia to advance analytical chemistry and foster groundbreaking scientific collaboration.

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

The Marlborough device maker is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder of a company in which it already owned a major stake. Boston ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial fibrillation. No hardware is being removed from use—instead, ...

Patients already treated don’t need to do anything. Boston Scientific has updated its instructions for doctors using catheter technology to treat atrial fibrillation with extreme cooling ...

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...